Elasmogen

Elasmogen is a privately-held biopharmaceutical company located in the thriving biologics cluster in Aberdeen, Scotland. The Company is rapidly progressing a pipeline of next-generation soloMER products for the treatment of solid-tumor cancers, systemic inflammatory diseases, and inflammatory conditions of the gut. Elasmogen was founded in 2016 and is based in the United Kingdom.